MRF | Jotup

Raheem Mostert, Miami Dolphins, Melanoma Supporter and Advocate, Gets Naked for Melanoma Awareness Month

Retrieved on:

星期三, 五月 1, 2024

WASHINGTON, May 1, 2024 /PRNewswire-PRWeb/ -- Decorated Running Back for the Miami Dolphins, Melanoma Supporter and Advocate Joins the Melanoma Research Foundation's #GetNaked Campaign to Promote Melanoma Prevention and Early Detection

Key Points:

The Melanoma Research Foundation (MRF) is pleased to announce the official launch of its annual award-winning #GetNaked campaign in recognition of Melanoma Awareness Month this May.
Miami Dolphins running back, Raheem Mostert will serve as this year's #GetNaked campaign spokesperson.
WASHINGTON, DC (May 1, 2024) – The Melanoma Research Foundation (MRF) is pleased to announce the official launch of its annual award-winning #GetNaked campaign in recognition of Melanoma Awareness Month this May.
To support critical melanoma research in finding effective treatments and a cure for melanoma, donate here .

Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood’s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma

Retrieved on:

星期二, 四月 30, 2024

The first such event is a ribbon cutting to honor the City of Friendswood’s designation as a Sun Safe Leadership Model City — the first in Texas — by IMPACT Melanoma.

Key Points:

The first such event is a ribbon cutting to honor the City of Friendswood’s designation as a Sun Safe Leadership Model City — the first in Texas — by IMPACT Melanoma.
“May is Skin Cancer Awareness Month, a time to educate people about the dangers of skin cancer, share information and help save lives.
That is why the City of Friendswood is proud to partner with IMPACT Melanoma and Castle Biosciences to designate Friendswood as a Sun Safe Leadership Model City,” said Foreman.
Julie Bain, skin cancer survivor and the senior director of science and education at The Skin Cancer Foundation, will also share her skin cancer journey.

BRIGHTMARK ANNOUNCES INTENT TO INVEST $950 MILLION IN UPSON COUNTY, GEORGIA TO TACKLE PLASTIC POLLUTION

Retrieved on:

星期二, 四月 23, 2024

THOMASTON, Ga., April 23, 2024 /PRNewswire/ -- Brightmark LLC, a circular solutions company with a mission to Reimagine Waste®, announced plans to develop a 2.5 million-square-foot circularity center in Thomaston, Georgia, with the capacity to repurpose over 400,000 tons of plastic per year. Brightmark's proprietary Plastics Renewal® technology takes discarded plastic content and converts it into the materials to create new circular plastic products, diverting waste otherwise bound for landfills, incinerators, and waterways.

Key Points:

Brightmark has been a Level One partner of the Georgia Recycling Coalition (GRC) since 2021 and supports conferences, recycling initiatives, and educational programs in partnership with GRC.
Brightmark selected the City of Thomaston because of its desire to grow alongside a strong community partner and responsible corporate actor.
Plastic pollution is a serious issue affecting our communities today: A staggering 95% of all plastic products in the U.S. do not get recycled.
Brightmark then converts these plastics into materials used to create new circular products that can be reused, reducing the need for new plastic.

Trek Health Launches Multi-Specialty Payer Transparency Platform at HIMSS 2024

Retrieved on:

星期三, 三月 13, 2024

Software, Practice Management, Insurance, Health, Data Management, Professional Services, Technology, Health Insurance, Intelligence, MRF, Patient, HIMSS, Multimedia, Health insurance

In a groundbreaking development poised to revolutionize healthcare transparency, Trek Health has officially unveiled its innovative Multi-Specialty Payer Transparency Platform during the Healthcare Information and Management Systems Society (HIMSS) 2024 conference in Orlando, Florida.

Key Points:

In a groundbreaking development poised to revolutionize healthcare transparency, Trek Health has officially unveiled its innovative Multi-Specialty Payer Transparency Platform during the Healthcare Information and Management Systems Society (HIMSS) 2024 conference in Orlando, Florida.
View the full release here: https://www.businesswire.com/news/home/20240313106050/en/
Trek Health launches innovative Multi-Specialty Payer Transparency Platform.
Key Features of the Trek Health Payer Transparency Platform:
Enhanced Transparency: By making detailed information about healthcare costs from Payer Machine Readable Files (MRF) easily accessible, the platform empowers healthcare organizations to make informed decisions about their Payer strategy.
Trek Health invites attendees of HIMSS 2024 to visit their booth for live demonstrations of the platform and to discuss the future of healthcare transparency with their team of experts.

Healthcare Financial Management Association calls Patient Rights Advocate’s latest price transparency compliance report ‘irresponsible’

Retrieved on:

星期四, 三月 7, 2024

Hospital, CMS, PRA, MRF, Editorial, Confusion, White, Health care, HFMA, Medicare, IRS, Patient, Finca, Insurance, Health insurance

CHICAGO, March 07, 2024 (GLOBE NEWSWIRE) -- Long an advocate for consumerism and price transparency in healthcare, the Healthcare Financial Management Association (HFMA) today called the latest report from Patient Rights Advocate (PRA) “irresponsible” and “incorrect.”

Key Points:

CHICAGO, March 07, 2024 (GLOBE NEWSWIRE) -- Long an advocate for consumerism and price transparency in healthcare, the Healthcare Financial Management Association (HFMA) today called the latest report from Patient Rights Advocate (PRA) “irresponsible” and “incorrect.”
HFMA has maintained that to be effective, price transparency must offer clear information that is readily accessible to patients to enable them to make meaningful comparisons among providers.
The latest PRA report asserts that only 34.5% of the 2,000 hospitals it reviewed are compliant with the federal price transparency regulations implemented in January 2021.
PRA’s results contradict the Centers for Medicare & Medicaid Services (CMS) scorecard, which last scored compliance at 70% of hospitals.
“Beyond disagreeing with CMS’s assessment, we see PRA is consistently misinterpreting federal rules in each of its reports,” Stack said.

Inaugural Award Poised to Advance Treatment Options for Uveal Melanoma Patients

Retrieved on:

星期五, 二月 16, 2024

WASHINGTON , Feb. 16, 2024 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) recently announced the winners of the inaugural CURE OM Options Bring Hope Team Science Award: Bruce Ksander, PhD from the Schepens Eye Research Institute; Rizwan Haq MD, PhD from the Dana-Farber Cancer Institute and Margarete Karg, PhD from Massachusetts Eye and Ear Infirmary. The collaborative research project is titled, "Identification of molecular pathways that drive uveal melanoma metastasis." The goal of the team's research is to determine the main factors that drive uveal melanoma (UM) to spread and specifically target the liver, with the hope that this research may guide the development of effective therapeutic interventions. Uveal melanoma is a type of ocular melanoma (OM) and is the most common type of eye cancer in adults that constitutes around 5 of all melanomas. In about half of all UM cases, the disease will spread to other parts of the body. When this occurs, it is almost always fatal.

Key Points:

The collaborative research project is titled, "Identification of molecular pathways that drive uveal melanoma metastasis."
Uveal melanoma is a type of ocular melanoma (OM) and is the most common type of eye cancer in adults that constitutes around 5 of all melanomas.
The CURE OM Options Bring Hope Team Science Award intends to support an interdisciplinary research team who is researching treatment options for metastatic UM patients not limited by HLA type.
To learn more about the CURE OM Options Bring Hope Team Science Award, read here .

Bollegraaf and Greyparrot Forge Strategic AI Partnership to Transform Global Waste Management Industry

Retrieved on:

星期三, 二月 7, 2024

Bollegraaf , the world's largest builder of recycling plants, has entered into a strategic partnership with Greyparrot , a pioneer in AI waste analytics, to transform global waste management.

Key Points:

Bollegraaf , the world's largest builder of recycling plants, has entered into a strategic partnership with Greyparrot , a pioneer in AI waste analytics, to transform global waste management.
In a development set to transform waste management, this marks a momentous acceleration in the global shift from a linear to a circular economy.
Greyparrot’s Analyzer gives 100% visibility into waste composition to unlock a new, more intelligent level of insight about waste that Greyparrot calls waste intelligence.
With automated, real-time waste monitoring and digitised systems powered by AI, the industry can tackle the issue of 'invisible waste' and transform a traditionally labour-intensive process.

Waste Eliminator Announces Opening of its New Material Recovery Facility

Retrieved on:

星期四, 一月 4, 2024

Heart, Growth, Compost, MSW, MRF, Recycling

ATLANTA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Waste Eliminator, the leader in sustainable waste solutions in the metro Atlanta area, announces the opening of its new state-of-the-art material recovery facility (MRF) located in Peachtree Corners, GA in the heart of the Atlanta metro area.

Key Points:

ATLANTA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Waste Eliminator, the leader in sustainable waste solutions in the metro Atlanta area, announces the opening of its new state-of-the-art material recovery facility (MRF) located in Peachtree Corners, GA in the heart of the Atlanta metro area.
With the opening of the new recycling facility, Waste Eliminator will increase its throughput capacity by 25%.
“As the leading provider of sustainable waste solutions in the Atlanta market, Waste Eliminator is proud to partner with our corporate clients as they move towards a circular economy model," said Kacy Cronan, Chief Executive Officer at Waste Eliminator.
“This new facility embodies the long-term vision of Waste Eliminator and will be a cornerstone for Atlanta’s sustainable vision ahead."

Scilex Holding Company Announces Market Research Results with Neurologists, Headache Specialists, and Primary Care Physicians Demonstrating Potential High Unmet Needs In Treating Acute Migraine Targeted By ELYXYB® with Potential Advantages Compared to Cal

Retrieved on:

星期三, 十一月 22, 2023

Sound, Conference, Contraindication, Migraine, Physician, Disability, CGRP, Chronic pain, Calcitonin gene-related peptide, Headache, Nausea, PALO, MRF, Light, Neurology, Exhibition, Patient, Dysgeusia, Pharmaceutical industry

A recent market research study (n=150) of Neurologists, Headache Specialists and Primary Care Physicians revealed that 93% of clinicians treating migraine have moderate to extremely high unmet needs for alternatives to triptan therapy.2 Clinicians stated their desire for fast and safe alternatives for two large pools of acute migraine patients – those who have an insufficient response to triptan therapy, and those who have contraindications to triptan use.

Key Points:

A recent market research study (n=150) of Neurologists, Headache Specialists and Primary Care Physicians revealed that 93% of clinicians treating migraine have moderate to extremely high unmet needs for alternatives to triptan therapy.2 Clinicians stated their desire for fast and safe alternatives for two large pools of acute migraine patients – those who have an insufficient response to triptan therapy, and those who have contraindications to triptan use.
ELYXYB’s product profile mapped with a high degree of certainty to these stated unmet needs.
In clinical studies, patients treated with ELYXYB® demonstrated pain relief in as little as 15 minutes, and significant pain relief compared to placebo within 45 minutes in nearly 50% of patients.
Approximately 34% of patients were pain free at two hours.3 Notably, these data are well differentiated from two other new oral migraine medications of a different class, calcitonin gene-related peptide (CGRP) receptor antagonists.

Clarify Health Recognized 10 Times in 2023 for High Customer Satisfaction and Product Innovation

Retrieved on:

星期二, 十二月 19, 2023

Key industry analysts and market intelligence platforms have recognized Clarify Health 10 times this year for delivering high customer satisfaction and innovation in healthcare analytics, value-based payments, and provider network management solutions.

Key Points:

Key industry analysts and market intelligence platforms have recognized Clarify Health 10 times this year for delivering high customer satisfaction and innovation in healthcare analytics, value-based payments, and provider network management solutions.
CB Insights included Clarify Health in its ‘Health insurance tech stack market map’ in the value-based contract management and provider network management categories.
“We are honored to be recognized by analysts and our customers for our technology and service innovation,” commented Clarify Health CEO Terry Boch.
All users said Clarify Health was easy to do business with and praised the quality of support provided.